Skip to content
Who we are
About us
Team
Board
Partnerships
Technology platform
Our technology
Manufacturing
Scientific publications and patents
Pipeline
Pipeline Overview
CEB-01
Clinical Trial CEB-01-RLS01-CT
Clinical Trial CEB-01-RLPC01-CT
Clinical Trial CEB-01-RLP01-CT
Investors
Invest in us
CEB-Shareholders Cebiotex
Shareholders Cebfunding
News
Contact
Who we are
About us
Team
Board
Partnerships
Technology platform
Our technology
Manufacturing
Scientific publications and patents
Pipeline
Pipeline Overview
CEB-01
Clinical Trial CEB-01-RLS01-CT
Clinical Trial CEB-01-RLPC01-CT
Clinical Trial CEB-01-RLP01-CT
Investors
Invest in us
CEB-Shareholders Cebiotex
Shareholders Cebfunding
News
Contact
Who we are
About us
Team
Board
Partnerships
Technology platform
Our technology
Manufacturing
Scientific publications and patents
Pipeline
Pipeline Overview
CEB-01
Clinical Trial CEB-01-RLS01-CT
Clinical Trial CEB-01-RLPC01-CT
Clinical Trial CEB-01-RLP01-CT
Investors
Invest in us
CEB-Shareholders Cebiotex
Shareholders Cebfunding
News
Contact
11/10/2020
La Vanguardia: “Ensayo de una biomembrana para tratar a recién operados de cáncer” (Spanish)
Haz clic aquí para leer el artículo:
You might also be interested in
Published paper Advanced Healthcare Materials 2018
Read more
Cebiotex awarded the Cecot Recognition of Innovation prize 2018
Founder and CEO Joan Bertran accepting the award. Cebiotex has
Read more